These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 35116406)
1. An inter-correlation among chemokine (C-X-C motif) ligand (CXCL) 1, CXCL2 and CXCL8, and their diversified potential as biomarkers for tumor features and survival profiles in non-small cell lung cancer patients. Gu L; Yao Y; Chen Z Transl Cancer Res; 2021 Feb; 10(2):748-758. PubMed ID: 35116406 [TBL] [Abstract][Full Text] [Related]
2. Associations of C-X-C motif chemokine ligands 1/2/8/13/14 with clinicopathological features and survival profile in patients with colorectal cancer. Luo X; Tai J; Zhao Y; Zhao P; Sun D; Wang L Oncol Lett; 2022 Oct; 24(4):348. PubMed ID: 36072008 [TBL] [Abstract][Full Text] [Related]
3. Correlations of AKIP1, CXCL1 and CXCL2 expressions with clinicopathological features and survival profiles in cervical cancer patients. Wan X; Hong Z; Mao Y; Di W Transl Cancer Res; 2020 Feb; 9(2):726-734. PubMed ID: 35117418 [TBL] [Abstract][Full Text] [Related]
4. A-kinase interacting protein 1 might serve as a novel biomarker for worse prognosis through the interaction of chemokine (C-X-C motif) ligand 1/chemokine (C-X-C motif) ligand 2 in acute myeloid leukemia. Hao X; Gu M; Sun J; Cong L J Clin Lab Anal; 2020 Feb; 34(2):e23052. PubMed ID: 31617252 [TBL] [Abstract][Full Text] [Related]
5. A-kinase interacting protein 1, a potential biomarker associated with advanced tumor features and CXCL1/2 in prostate cancer. Wang D; Luo Y; Guo Y; Li G; Li F Int J Biol Markers; 2020 Jun; 35(2):74-81. PubMed ID: 32339056 [TBL] [Abstract][Full Text] [Related]
6. Potential of C-X-C motif chemokine ligand 1/8/10/12 as diagnostic and prognostic biomarkers in idiopathic pulmonary arterial hypertension. Li Z; Jiang J; Gao S Clin Respir J; 2021 Dec; 15(12):1302-1309. PubMed ID: 34260815 [TBL] [Abstract][Full Text] [Related]
7. AKIP1 promotes glioblastoma viability, mobility and chemoradiation resistance via regulating CXCL1 and CXCL8 mediated NF-κB and AKT pathways. Han D; Zhang N; Zhao S; Liu H; Wang X; Yang M; Wang S; Li Y; Liu Z; Teng L Am J Cancer Res; 2021; 11(4):1185-1205. PubMed ID: 33948353 [TBL] [Abstract][Full Text] [Related]
8. Chemokine (C-X-C motif) ligand 1 is associated with tumor progression and poor prognosis in patients with colorectal cancer. Zhuo C; Wu X; Li J; Hu D; Jian J; Chen C; Zheng X; Yang C Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29784873 [TBL] [Abstract][Full Text] [Related]
9. The role of CXCL chemokine family in the development and progression of gastric cancer. Chen X; Chen R; Jin R; Huang Z Int J Clin Exp Pathol; 2020; 13(3):484-492. PubMed ID: 32269686 [TBL] [Abstract][Full Text] [Related]
10. The Clinicopathological Significance of the CXCR2 Ligands, CXCL1, CXCL2, CXCL3, CXCL5, CXCL6, CXCL7, and CXCL8 in Gastric Cancer. Yamamoto Y; Kuroda K; Sera T; Sugimoto A; Kushiyama S; Nishimura S; Togano S; Okuno T; Yoshii M; Tamura T; Toyokawa T; Tanaka H; Muguruma K; Ohira M; Yashiro M Anticancer Res; 2019 Dec; 39(12):6645-6652. PubMed ID: 31810929 [TBL] [Abstract][Full Text] [Related]
11. Complementary action of CXCL1 and CXCL8 in pathogenesis of gastric carcinoma. Chen X; Jin R; Chen R; Huang Z Int J Clin Exp Pathol; 2018; 11(2):1036-1045. PubMed ID: 31938199 [TBL] [Abstract][Full Text] [Related]
12. Identification of potential biomarkers of gout through weighted gene correlation network analysis. Wang X; Yang B; Xiong T; Qiu Y; Qin Y; Liang X; Lu D; Yang X Front Immunol; 2024; 15():1367019. PubMed ID: 38686389 [TBL] [Abstract][Full Text] [Related]
13. Integrin-α7 expression positively correlates with CD44 and CD133 expressions, and its high expression associates with advanced tumor features as well as poor survivals in non-small cell lung cancer patients. Shi X; Wen F; Xu G; Hu Y Transl Cancer Res; 2019 Sep; 8(5):1806-1816. PubMed ID: 35116931 [TBL] [Abstract][Full Text] [Related]
14. Chaperonin containing t-complex polypeptide 1 subunit 6A correlates with lymph node metastasis, abnormal carcinoembryonic antigen and poor survival profiles in non-small cell lung carcinoma. Zhang T; Shi W; Tian K; Kong Y World J Surg Oncol; 2020 Jul; 18(1):156. PubMed ID: 32631353 [TBL] [Abstract][Full Text] [Related]
15. Katanin P80 correlates with larger tumor size, lymph node metastasis, and advanced TNM stage and predicts poor prognosis in non-small-cell lung cancer patients. Ye Q; Zhang M; Yin Y J Clin Lab Anal; 2020 Apr; 34(4):e23141. PubMed ID: 31944409 [TBL] [Abstract][Full Text] [Related]
16. Chemokine (C-X-C motif) ligand 1 and CXCL2 produced by tumor promote the generation of monocytic myeloid-derived suppressor cells. Shi H; Han X; Sun Y; Shang C; Wei M; Ba X; Zeng X Cancer Sci; 2018 Dec; 109(12):3826-3839. PubMed ID: 30259595 [TBL] [Abstract][Full Text] [Related]
17. CXCL1 gene silencing inhibits HGC803 cell migration and invasion and acts as an independent prognostic factor for poor survival in gastric cancer. Wang L; Zhang C; Xu J; Wu H; Peng J; Cai S; He Y Mol Med Rep; 2016 Nov; 14(5):4673-4679. PubMed ID: 27748927 [TBL] [Abstract][Full Text] [Related]
18. A new clinical prognostic nomogram for liver cancer based on immune score. Shen Q; Hu G; Wu J; Lv L PLoS One; 2020; 15(7):e0236622. PubMed ID: 32730361 [TBL] [Abstract][Full Text] [Related]
19. Association of chemokine and chemokine receptor expression with the invasion and metastasis of lung carcinoma. Liu Y; Wu BQ; Geng H; Xu ML; Zhong HH Oncol Lett; 2015 Sep; 10(3):1315-1322. PubMed ID: 26622670 [TBL] [Abstract][Full Text] [Related]
20. A-kinase-interacting protein 1 overexpression correlates with deteriorative tumor features and worse survival profiles, and promotes cell proliferation but represses apoptosis in non-small-cell lung cancer. Chen H; Yan S; Dong L; Li X J Clin Lab Anal; 2020 Feb; 34(2):e23061. PubMed ID: 31828834 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]